{"name":"Kyungdong Pharmaceutical Co., Ltd.","slug":"kyungdong-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"KDF1901-R1","genericName":"KDF1901-R1","slug":"kdf1901-r1","indication":"Type 2 diabetes","status":"phase_3"},{"name":"KDF1901-L","genericName":"KDF1901-L","slug":"kdf1901-l","indication":"Type 2 diabetes","status":"phase_3"},{"name":"KDF1901-R0","genericName":"KDF1901-R0","slug":"kdf1901-r0","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"KDF1901","genericName":"KDF1901","slug":"kdf1901","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"KDF1901-R1","genericName":"KDF1901-R1","slug":"kdf1901-r1","phase":"phase_3","mechanism":"KDF1901-R1 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"KDF1901","genericName":"KDF1901","slug":"kdf1901","phase":"phase_3","mechanism":"KDF1901 is an investigational therapeutic agent in phase 3 development by Kyungdong Pharmaceutical, but its specific mechanism of action has not been publicly disclosed.","indications":[],"catalyst":""},{"name":"KDF1901-L","genericName":"KDF1901-L","slug":"kdf1901-l","phase":"phase_3","mechanism":"KDF1901-L is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"KDF1901-R0","genericName":"KDF1901-R0","slug":"kdf1901-r0","phase":"phase_3","mechanism":"KDF1901-R0 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPY2IzOHRaMWxITzlncERQXzd6bUJQRzZuMWM2RlZhU0Q0aUE0SlR4R0pFbF9DOFNXRnpJLVNCWHFQZFRuY3FKeGRVbWt4RjlEbWo2OGNUY0JVcUg4M2NCXy1yaXFoRDNkU080TXFmODh5UjZzMWdDSmJuY1NQV0pLUWVB0gGWAUFVX3lxTE9STXA0MW1WaWdfNzlGY0ZyZ2RyV1ZXVGQzUWdvOEVCdGVLSVJxRzlkaWtFeFh5NlhOU1BVV3ZRTnRKRkZGa2ZzMUtMVUtZdWhPMHR5WmxfdlRMbnpQdkp2NWFvTUhxMktQVnNxREdNaG1VVjJrWWJQemdGa3A1Vnc3anRPelhSVS10T2IxTWpFbXotOHp4Zw?oc=5","date":"2026-01-27","type":"pipeline","source":"Chosunbiz","summary":"South Korea SMEs accelerate M&A for growth and succession - CHOSUNBIZ - Chosunbiz","headline":"South Korea SMEs accelerate M&A for growth and succession - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9YSk50SjMyVGpBQ3JFZDFaSmlWZ2dxend4NXhtUGdkem9HeHNma0RVdTRGX3YtWW9aVExiYXdOTXZqS0VpTnNtUGVHR0h2bXJ2TDF3ZEZHakdlYm5SblZoSmhDSDRiaTZNaFg2ZFZR0gFyQVVfeXFMUEdHUlg3Q2xmVDhhckRFWW5Rcm9vY0w3MVJVTHZNOE9acjFaOVBUQ3pFdGVXM0Iwd2pLbUpPWVFCRjUzc0ZUN2Q2TnVuR0RhLTI4Z3JwaHNrVGJUNXl6YWdyZHQwbWxWb3I5VFlfMzBmWEhR?oc=5","date":"2024-05-16","type":"pipeline","source":"koreabiomed.com","summary":"Regulator orders Kukje Pharma to recall fluoxetine hydrochloride products - koreabiomed.com","headline":"Regulator orders Kukje Pharma to recall fluoxetine hydrochloride products","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":4},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}